Dr. Reddy's Lab, Promius Pharma receive USFDA’s approval for TOSYMRA

28 Jan 2019 Evaluate

Dr. Reddy's Laboratories and its subsidiary, Promius Pharma, LLC have received approval for TOSYMRA (previously known as DFN-02) from the US Food and Drug Administration (USFDA). TOSYMRA is indicated for the acute treatment of migraine with or without aura in adults.

TOSYMRA is the latest product to join the Promius Pharma acute migraine treatment portfolio. The company is working toward commercialization of this product.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×